Amongst them, 33 (25.2%) have been reported as GBM-related (e.g., EGFR, PTEN, MTOR) and 29 (22.1%) as cancer-associated genes (e.g., AGAP2, SOX2). This evidence concerns the gene SOX2 and glioblastoma.